CICLOSPORIN 0.09% EYE DROPS (Cequa®)
Clinical Indication
Treatment of moderate-to-severe Dry Eye Disease
Comments
An alternative preparation to Ikervis®
Date of classification
April 2026
Yellow
Specialist recommendation: Medicines initiated (and stabilised where appropriate) or recommended by a specialist service for prescribing in primary care. Requests should be clearly communicated either through written communication including using approved paperwork if available or verbal means as appropriate .